ChemoTech develops Tumour Specific Electroporation™ (TSE) for applications in human oncology. The technology is designed to enhance the local effect of anti-cancer drugs through controlled electrical stimulation while limiting unnecessary destruction of healthy surrounding tissue.
Our initial clinical and commercial focus is on selected superficial tumours, with IQwave™ providing physicians with a flexible platform for treatment in sensitive and difficult-to-access anatomical areas.
ChemoTech is also advancing the development of TSE for selected deep-seated tumours through clinical collaborations and technology development. These programmes are intended to broaden the future clinical applications of the TSE platform in human cancer care.
Get in touch
Are you interested in our products?
Our team is here to help with any questions about our products, patents or anything else you may need help with.
This website uses cookies. If you continue to browse the website, you agree to the use of cookies.